Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Non-Current Assets (2019 - 2025)

Legend Biotech filings provide 7 years of Non-Current Assets readings, the most recent being $486.6 million for Q4 2025.

  • On a quarterly basis, Non-Current Assets rose 25.96% to $486.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $486.6 million, a 25.96% increase, with the full-year FY2025 number at $486.6 million, up 25.96% from a year prior.
  • Non-Current Assets hit $486.6 million in Q4 2025 for Legend Biotech, up from $470.9 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $486.6 million in Q4 2025 to a low of $140179.0 in Q1 2021.
  • Median Non-Current Assets over the past 5 years was $340.7 million (2023), compared with a mean of $305.0 million.
  • Biggest five-year swings in Non-Current Assets: soared 155006.86% in 2021 and later grew 9.84% in 2025.
  • Legend Biotech's Non-Current Assets stood at $169.6 million in 2021, then skyrocketed by 36.69% to $231.8 million in 2022, then skyrocketed by 51.31% to $350.8 million in 2023, then rose by 10.12% to $386.3 million in 2024, then increased by 25.96% to $486.6 million in 2025.
  • The last three reported values for Non-Current Assets were $486.6 million (Q4 2025), $470.9 million (Q3 2025), and $440.0 million (Q2 2025) per Business Quant data.